HERV-K activation is strictly required to sustain CD133+ melanoma cells with stemness features

BACKGROUND: Melanoma is a heterogeneous tumor in which phenotype-switching and CD133 marker have been associated with metastasis promotion and chemotherapy resistance. CD133 positive (CD133+) subpopulation has also been suggested as putative cancer stem cell (CSC) of melanoma tumor. Human endogenous...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Exp Clin Cancer Res
Main Authors: Argaw-Denboba, Ayele, Balestrieri, Emanuela, Serafino, Annalucia, Cipriani, Chiara, Bucci, Ilaria, Sorrentino, Roberta, Sciamanna, Ilaria, Gambacurta, Alessandra, Sinibaldi-Vallebona, Paola, Matteucci, Claudia
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5270369/
https://ncbi.nlm.nih.gov/pubmed/28125999
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-016-0485-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados